Skip to main content
Erschienen in: Endocrine 2/2019

03.06.2019 | Original Article

High dose of linagliptin induces thermogenic beige adipocytes in the subcutaneous white adipose tissue in diet-induced obese C57BL/6 mice

verfasst von: Byanca Ramos de Oliveira Correia, Tamiris Lima Rachid, Jade Sancha de Oliveira Glauser, Fabiane Ferreira Martins, Carlos Alberto Mandarim-de-Lacerda, Vanessa Souza-Mello

Erschienen in: Endocrine | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To verify whether the treatment with linagliptin induces the browning of the subcutaneous WAT (sWAT) and thermogenesis in murine diet-induced obesity (DIO) model.

Methods

Forty animals were randomly assigned to receive a control diet (C, 10% lipids as energy) or a high-fat diet (HF, 50% lipids as energy) for 10 weeks. Each group was re-divided to begin the 5-week treatment, totalizing four experimental groups: C, C-L (C plus linagliptin, 30 mg/kg body mass; BM), HF, and HF-L (HF plus linagliptin, 30 mg/kg BM). The drug was mixed with diet.

Results

HF animals showed overweight, glucose intolerance, and a greater cross-sectional area of adipocytes. The treatment with linagliptin was able to normalize the BM, restore the glucose tolerance and the cross-sectional area of adipocytes. These observations comply with the observation of UCP1-positive multilocular adipocytes in the sWAT of treated animals. Both treated groups (C-L and HF-L) showed high expression of thermogenic and type 2 cytokines genes, which agree with the enhanced body temperature and the lower respiratory exchange ratio, implying enhanced thermogenesis with the use of lipids as fuel.

Conclusions

The reduced BM, the enhanced body temperature, and the presence of positive UCP1 beige cells in the sWAT point to the activation of the browning cascade on the sWAT of linagliptin-treated mice, and hence, linagliptin could induce the thermogenic pathway as a pleiotropic effect that can have translational potential.
Literatur
2.
Zurück zum Zitat B. Gustafson, S. Hedjazifar, S. Gogg, A. Hammarstedt, U. Smith, Insulin resistance and impaired adipogenesis. Trends Endocrinol. Metab. 26(4), 193–200 (2015)CrossRefPubMed B. Gustafson, S. Hedjazifar, S. Gogg, A. Hammarstedt, U. Smith, Insulin resistance and impaired adipogenesis. Trends Endocrinol. Metab. 26(4), 193–200 (2015)CrossRefPubMed
3.
Zurück zum Zitat B. Gustafson, U. Smith, Regulation of white adipogenesis and its relation to ectopic fat accumulation and cardiovascular risk. Atherosclerosis 241(1), 27–35 (2015)CrossRefPubMed B. Gustafson, U. Smith, Regulation of white adipogenesis and its relation to ectopic fat accumulation and cardiovascular risk. Atherosclerosis 241(1), 27–35 (2015)CrossRefPubMed
4.
Zurück zum Zitat R.S. Ahima, Adipose tissue as an endocrine organ. Obes. (Silver Spring). 14(Suppl 5), 242S–249S (2006)CrossRef R.S. Ahima, Adipose tissue as an endocrine organ. Obes. (Silver Spring). 14(Suppl 5), 242S–249S (2006)CrossRef
5.
Zurück zum Zitat A. Rodriguez, S. Ezquerro, L. Mendez-Gimenez, S. Becerril, G. Fruhbeck, Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. Am. J. Physiol. Endocrinol. Metab. 309(8), E691–E714 (2015)CrossRefPubMed A. Rodriguez, S. Ezquerro, L. Mendez-Gimenez, S. Becerril, G. Fruhbeck, Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. Am. J. Physiol. Endocrinol. Metab. 309(8), E691–E714 (2015)CrossRefPubMed
7.
Zurück zum Zitat J. Nedergaard, B. Cannon, The browning of white adipose tissue: some burning issues. Cell Metab. 20(3), 396–407 (2014)CrossRefPubMed J. Nedergaard, B. Cannon, The browning of white adipose tissue: some burning issues. Cell Metab. 20(3), 396–407 (2014)CrossRefPubMed
8.
Zurück zum Zitat K.A. Virtanen, M.E. Lidell, J. Orava, M. Heglind, R. Westergren, T. Niemi et al., Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 360(15), 1518–1525 (2009)CrossRefPubMed K.A. Virtanen, M.E. Lidell, J. Orava, M. Heglind, R. Westergren, T. Niemi et al., Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 360(15), 1518–1525 (2009)CrossRefPubMed
9.
Zurück zum Zitat T.L. Rachid, A. Penna-de-Carvalho, I. Bringhenti, M.B. Aguila, C.A. Mandarim-de-Lacerda, V. Souza-Mello, Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice. Mol. Cell Endocrinol. 402, 86–94 (2015)CrossRefPubMed T.L. Rachid, A. Penna-de-Carvalho, I. Bringhenti, M.B. Aguila, C.A. Mandarim-de-Lacerda, V. Souza-Mello, Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice. Mol. Cell Endocrinol. 402, 86–94 (2015)CrossRefPubMed
10.
Zurück zum Zitat T.L. Rachid, F.M. Silva-Veiga, F. Graus-Nunes, I. Bringhenti, C.A. Mandarim-de-Lacerda, V. Souza-Mello, Differential actions of PPAR-alpha and PPAR-beta/delta on beige adipocyte formation: a study in the subcutaneous white adipose tissue of obese male mice. PLoS ONE 13(1), e0191365 (2018)CrossRefPubMedPubMedCentral T.L. Rachid, F.M. Silva-Veiga, F. Graus-Nunes, I. Bringhenti, C.A. Mandarim-de-Lacerda, V. Souza-Mello, Differential actions of PPAR-alpha and PPAR-beta/delta on beige adipocyte formation: a study in the subcutaneous white adipose tissue of obese male mice. PLoS ONE 13(1), e0191365 (2018)CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat F. Graus-Nunes, T.L. Rachid, de Oliveira Santos, F., Barbosa-da-Silva, S., Souza-Mello, V., AT1 receptor antagonist induces thermogenic beige adipocytes in the inguinal white adipose tissue of obese mice. Endocrine 55(3), 786–798 (2017). F. Graus-Nunes, T.L. Rachid, de Oliveira Santos, F., Barbosa-da-Silva, S., Souza-Mello, V., AT1 receptor antagonist induces thermogenic beige adipocytes in the inguinal white adipose tissue of obese mice. Endocrine 55(3), 786–798 (2017).
12.
13.
Zurück zum Zitat J.H. Choi, J.W. Yun, Chrysin induces brown fat-like phenotype and enhances lipid metabolism in 3T3-L1 adipocytes. Nutrition 32(9), 1002–1010 (2016)CrossRefPubMed J.H. Choi, J.W. Yun, Chrysin induces brown fat-like phenotype and enhances lipid metabolism in 3T3-L1 adipocytes. Nutrition 32(9), 1002–1010 (2016)CrossRefPubMed
14.
Zurück zum Zitat D. Lamers, S. Famulla, N. Wronkowitz, S. Hartwig, S. Lehr, D.M. Ouwens et al., Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60(7), 1917–1925 (2011)CrossRefPubMedPubMedCentral D. Lamers, S. Famulla, N. Wronkowitz, S. Hartwig, S. Lehr, D.M. Ouwens et al., Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60(7), 1917–1925 (2011)CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat H. Sell, M. Bluher, N. Kloting, R. Schlich, M. Willems, F. Ruppe et al., Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care. 36(12), 4083–4090 (2013)CrossRefPubMedPubMedCentral H. Sell, M. Bluher, N. Kloting, R. Schlich, M. Willems, F. Ruppe et al., Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care. 36(12), 4083–4090 (2013)CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat V. Souza-Mello, B.M. Gregorio, F.S. Cardoso-de-Lemos, L. de Carvalho, M.B. Aguila, C.A. Mandarim-de-Lacerda, Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet. Clin. Sci. (Lond.). 119(6), 239–250 (2010)CrossRefPubMed V. Souza-Mello, B.M. Gregorio, F.S. Cardoso-de-Lemos, L. de Carvalho, M.B. Aguila, C.A. Mandarim-de-Lacerda, Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet. Clin. Sci. (Lond.). 119(6), 239–250 (2010)CrossRefPubMed
17.
Zurück zum Zitat F. Zhuge, Y. Ni, M. Nagashimada, N. Nagata, L. Xu, N. Mukaida et al., DPP-4 inhibition by linagliptin attenuates obesity-related inflammation and insulin resistance by regulating M1/M2 macrophage polarization. Diabetes 65(10), 2966–2979 (2016)CrossRefPubMed F. Zhuge, Y. Ni, M. Nagashimada, N. Nagata, L. Xu, N. Mukaida et al., DPP-4 inhibition by linagliptin attenuates obesity-related inflammation and insulin resistance by regulating M1/M2 macrophage polarization. Diabetes 65(10), 2966–2979 (2016)CrossRefPubMed
18.
Zurück zum Zitat N. Jeremic, P. Chaturvedi, S.C. Tyagi, Browning of white fat: novel insight into factors, mechanisms, and therapeutics. J. Cell Physiol. 232(1), 61–68 (2017)CrossRefPubMed N. Jeremic, P. Chaturvedi, S.C. Tyagi, Browning of white fat: novel insight into factors, mechanisms, and therapeutics. J. Cell Physiol. 232(1), 61–68 (2017)CrossRefPubMed
19.
Zurück zum Zitat M. Kern, N. Kloting, H.G. Niessen, L. Thomas, D. Stiller, M. Mark et al., Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity. PLoS ONE 7(6), e38744 (2012)CrossRefPubMedPubMedCentral M. Kern, N. Kloting, H.G. Niessen, L. Thomas, D. Stiller, M. Mark et al., Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity. PLoS ONE 7(6), e38744 (2012)CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat P.G. Reeves, F.H. Nielsen, G.C. Fahey Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123(11), 1939–1951 (1993)CrossRefPubMed P.G. Reeves, F.H. Nielsen, G.C. Fahey Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123(11), 1939–1951 (1993)CrossRefPubMed
21.
Zurück zum Zitat A. Penna-de-Carvalho, F. Graus-Nunes, J. Rabelo-Andrade, C.A. Mandarim-de-Lacerda, V. Souza-Mello, Enhanced pan-peroxisome proliferator-activated receptor gene and protein expression in adipose tissue of diet-induced obese mice treated with telmisartan. Exp. Physiol. 99(12), 1663–1678 (2014)CrossRefPubMed A. Penna-de-Carvalho, F. Graus-Nunes, J. Rabelo-Andrade, C.A. Mandarim-de-Lacerda, V. Souza-Mello, Enhanced pan-peroxisome proliferator-activated receptor gene and protein expression in adipose tissue of diet-induced obese mice treated with telmisartan. Exp. Physiol. 99(12), 1663–1678 (2014)CrossRefPubMed
22.
Zurück zum Zitat S.A. Tschanz, P.H. Burri, E.R. Weibel, A simple tool for stereological assessment of digital images: the STEPanizer. J. Microsc. 243(1), 47–59 (2011)CrossRefPubMed S.A. Tschanz, P.H. Burri, E.R. Weibel, A simple tool for stereological assessment of digital images: the STEPanizer. J. Microsc. 243(1), 47–59 (2011)CrossRefPubMed
23.
Zurück zum Zitat C.A. Mandarim-De-Lacerda, Stereological tools in biomedical research. An. Acad. Bras. Cienc. 75(4), 469–486 (2003)CrossRefPubMed C.A. Mandarim-De-Lacerda, Stereological tools in biomedical research. An. Acad. Bras. Cienc. 75(4), 469–486 (2003)CrossRefPubMed
24.
Zurück zum Zitat M.T. Davisson, Rules and guidelines for nomenclature of mouse genes. International Committee on Standardized Genetic Nomenclature for Mice. Gene 147, 157–160 (1994)CrossRefPubMed M.T. Davisson, Rules and guidelines for nomenclature of mouse genes. International Committee on Standardized Genetic Nomenclature for Mice. Gene 147, 157–160 (1994)CrossRefPubMed
25.
Zurück zum Zitat M. Eckhardt, E. Langkopf, M. Mark, M. Tadayyon, L. Thomas, H. Nar et al., 8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylme thyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes. J. Med Chem. 50(26), 6450–6453 (2007)CrossRefPubMed M. Eckhardt, E. Langkopf, M. Mark, M. Tadayyon, L. Thomas, H. Nar et al., 8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylme thyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes. J. Med Chem. 50(26), 6450–6453 (2007)CrossRefPubMed
26.
Zurück zum Zitat J.B. McGill, Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials. Ther. Adv. Endocrinol. Metab. 3(4), 113–124 (2012)CrossRefPubMedPubMedCentral J.B. McGill, Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials. Ther. Adv. Endocrinol. Metab. 3(4), 113–124 (2012)CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat S. Del Prato, A.H. Barnett, H. Huisman, D. Neubacher, H.J. Woerle, K.A. Dugi, Effect of linagliptin monotherapy on glycaemic control and markers of beta-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. Diabetes Obes. Metab. 13(3), 258–267 (2011)CrossRefPubMed S. Del Prato, A.H. Barnett, H. Huisman, D. Neubacher, H.J. Woerle, K.A. Dugi, Effect of linagliptin monotherapy on glycaemic control and markers of beta-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. Diabetes Obes. Metab. 13(3), 258–267 (2011)CrossRefPubMed
28.
Zurück zum Zitat I. Shimizu, K. Walsh, The whitening of brown fat and its implications for weight management in obesity. Curr. Obes. Rep. 4(2), 224–229 (2015)CrossRefPubMed I. Shimizu, K. Walsh, The whitening of brown fat and its implications for weight management in obesity. Curr. Obes. Rep. 4(2), 224–229 (2015)CrossRefPubMed
29.
Zurück zum Zitat D. Duteil, M. Tosic, F. Lausecker, H.Z. Nenseth, J.M. Muller, S. Urban et al., Lsd1 ablation triggers metabolic reprogramming of brown adipose tissue. Cell Rep. 17(4), 1008–1021 (2016)CrossRefPubMedPubMedCentral D. Duteil, M. Tosic, F. Lausecker, H.Z. Nenseth, J.M. Muller, S. Urban et al., Lsd1 ablation triggers metabolic reprogramming of brown adipose tissue. Cell Rep. 17(4), 1008–1021 (2016)CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat J.R. Arch, D. Hislop, S.J. Wang, J.R. Speakman, Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals. Int J. Obes. 30(9), 1322–1331 (2006)CrossRef J.R. Arch, D. Hislop, S.J. Wang, J.R. Speakman, Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals. Int J. Obes. 30(9), 1322–1331 (2006)CrossRef
32.
Zurück zum Zitat D. Ricquier, UCP1, the mitochondrial uncoupling protein of brown adipocyte: a personal contribution and a historical perspective. Biochimie 134, 3–8 (2017)CrossRefPubMed D. Ricquier, UCP1, the mitochondrial uncoupling protein of brown adipocyte: a personal contribution and a historical perspective. Biochimie 134, 3–8 (2017)CrossRefPubMed
33.
Zurück zum Zitat D. Ricquier, B. Miroux, M. Larose, A.M. Cassard-Doulcier, F. Bouillaud, Endocrine regulation of uncoupling proteins and energy expenditure. Int J. Obes. Relat. Metab. Disord. 24(Suppl 2), S86–S88 (2000)CrossRefPubMed D. Ricquier, B. Miroux, M. Larose, A.M. Cassard-Doulcier, F. Bouillaud, Endocrine regulation of uncoupling proteins and energy expenditure. Int J. Obes. Relat. Metab. Disord. 24(Suppl 2), S86–S88 (2000)CrossRefPubMed
34.
Zurück zum Zitat B.M. Spiegelman, Banting Lecture 2012: regulation of adipogenesis: toward new therapeutics for metabolic disease. Diabetes 62(6), 1774–1782 (2013)CrossRefPubMedPubMedCentral B.M. Spiegelman, Banting Lecture 2012: regulation of adipogenesis: toward new therapeutics for metabolic disease. Diabetes 62(6), 1774–1782 (2013)CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat A.V. Kalinovich, J.M. de Jong, B. Cannon, J. Nedergaard, UCP1 in adipose tissues: two steps to full browning. Biochimie 134, 127–137 (2017)CrossRefPubMed A.V. Kalinovich, J.M. de Jong, B. Cannon, J. Nedergaard, UCP1 in adipose tissues: two steps to full browning. Biochimie 134, 127–137 (2017)CrossRefPubMed
36.
Zurück zum Zitat M. Jimenez, G. Barbatelli, R. Allevi, S. Cinti, J. Seydoux, J.P. Giacobino et al., Beta 3-adrenoceptor knockout in C57BL/6J mice depresses the occurrence of brown adipocytes in white fat. Eur. J. Biochem. 270(4), 699–705 (2003)CrossRefPubMed M. Jimenez, G. Barbatelli, R. Allevi, S. Cinti, J. Seydoux, J.P. Giacobino et al., Beta 3-adrenoceptor knockout in C57BL/6J mice depresses the occurrence of brown adipocytes in white fat. Eur. J. Biochem. 270(4), 699–705 (2003)CrossRefPubMed
37.
Zurück zum Zitat O. Braissant, F. Foufelle, C. Scotto, M. Dauca, W. Wahli, Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137(1), 354–366 (1996)CrossRefPubMed O. Braissant, F. Foufelle, C. Scotto, M. Dauca, W. Wahli, Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137(1), 354–366 (1996)CrossRefPubMed
38.
Zurück zum Zitat F.M.S. Veiga, F. Graus-Nunes, T.L. Rachid, A.B. Barreto, C.A. Mandarim-de-Lacerda, V. Souza-Mello, Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice. Biochimie 140, 106–116 (2017)CrossRefPubMed F.M.S. Veiga, F. Graus-Nunes, T.L. Rachid, A.B. Barreto, C.A. Mandarim-de-Lacerda, V. Souza-Mello, Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice. Biochimie 140, 106–116 (2017)CrossRefPubMed
39.
Zurück zum Zitat D. Namgaladze, S. Lips, T.J. Leiker, R.C. Murphy, K. Ekroos, N. Ferreiros et al., Inhibition of macrophage fatty acid beta-oxidation exacerbates palmitate-induced inflammatory and endoplasmic reticulum stress responses. Diabetologia 57(5), 1067–1077 (2014)CrossRefPubMed D. Namgaladze, S. Lips, T.J. Leiker, R.C. Murphy, K. Ekroos, N. Ferreiros et al., Inhibition of macrophage fatty acid beta-oxidation exacerbates palmitate-induced inflammatory and endoplasmic reticulum stress responses. Diabetologia 57(5), 1067–1077 (2014)CrossRefPubMed
40.
Zurück zum Zitat D.A. Chistiakov, M.C. Killingsworth, V.A. Myasoedova, A.N. Orekhov, Y.V. Bobryshev, CD68/macrosialin: not just a histochemical marker. Lab. Invest. 97(1), 4–13 (2017)CrossRefPubMed D.A. Chistiakov, M.C. Killingsworth, V.A. Myasoedova, A.N. Orekhov, Y.V. Bobryshev, CD68/macrosialin: not just a histochemical marker. Lab. Invest. 97(1), 4–13 (2017)CrossRefPubMed
41.
Zurück zum Zitat J. Chylikova, J. Dvorackova, K. Cizkova, H. Lacey, V. Kamarad, Macrophages of the subcutaneous and omental fatty tissue in obese patients: Immunohistochemical phenotyping of M2 subtypes in relation to type 2 diabetes. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub (2019). https://doi.org/10.5507/bp.2019.011 J. Chylikova, J. Dvorackova, K. Cizkova, H. Lacey, V. Kamarad, Macrophages of the subcutaneous and omental fatty tissue in obese patients: Immunohistochemical phenotyping of M2 subtypes in relation to type 2 diabetes. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub (2019). https://​doi.​org/​10.​5507/​bp.​2019.​011
42.
Zurück zum Zitat P. Seale, B. Bjork, W. Yang, S. Kajimura, S. Chin, S. Kuang et al., PRDM16 controls a brown fat/skeletal muscle switch. Nature 454(7207), 961–967 (2008)CrossRefPubMedPubMedCentral P. Seale, B. Bjork, W. Yang, S. Kajimura, S. Chin, S. Kuang et al., PRDM16 controls a brown fat/skeletal muscle switch. Nature 454(7207), 961–967 (2008)CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Y. Qiu, K.D. Nguyen, J.I. Odegaard, X. Cui, X. Tian, R.M. Locksley et al., Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 157(6), 1292–1308 (2014)CrossRefPubMedPubMedCentral Y. Qiu, K.D. Nguyen, J.I. Odegaard, X. Cui, X. Tian, R.M. Locksley et al., Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 157(6), 1292–1308 (2014)CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat M.W. Lee, J.I. Odegaard, L. Mukundan, Y. Qiu, A.B. Molofsky, J.C. Nussbaum et al., Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 160(1–2), 74–87 (2015)CrossRefPubMed M.W. Lee, J.I. Odegaard, L. Mukundan, Y. Qiu, A.B. Molofsky, J.C. Nussbaum et al., Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 160(1–2), 74–87 (2015)CrossRefPubMed
45.
Zurück zum Zitat X. Ding, Y. Luo, X. Zhang, H. Zheng, X. Yang, M. Liu, IL-33-driven ILC2/eosinophil axis in fat is induced by sympathetic tone and suppressed by obesity. J. Endocrinol. 231(1), 35–48 (2016)CrossRefPubMedPubMedCentral X. Ding, Y. Luo, X. Zhang, H. Zheng, X. Yang, M. Liu, IL-33-driven ILC2/eosinophil axis in fat is induced by sympathetic tone and suppressed by obesity. J. Endocrinol. 231(1), 35–48 (2016)CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat T. Forst, B. Uhlig-Laske, A. Ring, U. Graefe-Mody, C. Friedrich, K. Herbach et al., Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes. Diabet. Med. 27(12), 1409–1419 (2010)CrossRefPubMed T. Forst, B. Uhlig-Laske, A. Ring, U. Graefe-Mody, C. Friedrich, K. Herbach et al., Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes. Diabet. Med. 27(12), 1409–1419 (2010)CrossRefPubMed
47.
Zurück zum Zitat R. Kawamori, M. Haneda, K. Suzaki, G. Cheng, K. Shiki, Y. Miyamoto, et al., Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial. Diabetes Obes. Metab. 20(9), 2200–2209 (2018)CrossRefPubMedPubMedCentral R. Kawamori, M. Haneda, K. Suzaki, G. Cheng, K. Shiki, Y. Miyamoto, et al., Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial. Diabetes Obes. Metab. 20(9), 2200–2209 (2018)CrossRefPubMedPubMedCentral
Metadaten
Titel
High dose of linagliptin induces thermogenic beige adipocytes in the subcutaneous white adipose tissue in diet-induced obese C57BL/6 mice
verfasst von
Byanca Ramos de Oliveira Correia
Tamiris Lima Rachid
Jade Sancha de Oliveira Glauser
Fabiane Ferreira Martins
Carlos Alberto Mandarim-de-Lacerda
Vanessa Souza-Mello
Publikationsdatum
03.06.2019
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01969-y

Weitere Artikel der Ausgabe 2/2019

Endocrine 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.